These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22640986)

  • 1. Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
    Nochioka K; Tanaka S; Miura M; Zhulanqiqige do E; Fukumoto Y; Shiba N; Shimokawa H
    Circ J; 2012; 76(8):2023-30. PubMed ID: 22640986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to use ezetimibe as an anti-atherogenic agent via inhibition of Rho-kinase.
    Noma K; Higashi Y
    Circ J; 2012; 76(8):1836-7. PubMed ID: 22785339
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.
    Liu PY; Liu YW; Lin LJ; Chen JH; Liao JK
    Circulation; 2009 Jan; 119(1):131-8. PubMed ID: 19075102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
    Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
    J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
    Niesor EJ; Chaput E; Staempfli A; Blum D; Derks M; Kallend D
    Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia.
    Grigore L; Raselli S; Garlaschelli K; Redaelli L; Norata GD; Pirillo A; Catapano AL
    Eur J Clin Pharmacol; 2013 Mar; 69(3):341-6. PubMed ID: 22777149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy.
    Nakamura T; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Obata JE; Watanabe Y; Watanabe K; Kugiyama K
    J Cardiol; 2012 Jul; 60(1):12-7. PubMed ID: 22445441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation.
    Dagli N; Yavuzkir M; Karaca I
    Inflammation; 2007 Dec; 30(6):230-5. PubMed ID: 17687635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
    Berthold HK; Naini A; Di Mauro S; Hallikainen M; Gylling H; Krone W; Gouni-Berthold I
    Drug Saf; 2006; 29(8):703-12. PubMed ID: 16872244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
    Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K
    Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus.
    Vera-Lastra O; Méndez-Flores S; Cruz-Dominguez MP; Medina G; Calderón-Aranda E; Jara LJ
    Lupus; 2016 Jun; 25(7):741-8. PubMed ID: 26923285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
    Nozue T; Michishita I; Mizuguchi I
    J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ezetimibe in patients undergoing hemodialysis.
    Hattori S; Hattori Y
    Endocr J; 2010; 57(11):1001-5. PubMed ID: 20885068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
    Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K
    Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An inhibitor of intestinal cholesterol transporter].
    Sano M
    Nihon Rinsho; 2013 Sep; 71(9):1661-6. PubMed ID: 24205731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.